Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07222176 · ClinicalTrials.gov registry record · NA
Effects of P-TIOX and Tixel Combined on Reducing Eye Wrinkles
A NA study of Periocular Fine Wrinkles, sponsored by Main Line Center for Laser Surgery.
- Active
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT07222176: Active NA study of Periocular Fine Wrinkles, sponsored by Main Line Center for Laser Surgery.
NCT07222176 is a NA study of Periocular Fine Wrinkles that is active but no longer recruiting, run by Main Line Center for Laser Surgery. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07222176, a NA study of Periocular Fine Wrinkles, is active but no longer recruiting, sponsored by Main Line Center for Laser Surgery.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This study looks at whether using a cosmeceutical called P-TIOX together with a treatment called Tixel can reduce fine lines and wrinkles around the eyes better than Tixel treatment alone. Tixel is an FDA-approved device that uses heat to improve skin texture and firmness. P-TIOX is a topical product with ingredients that may help improve the skin's appearance and elasticity. One side of the face will be treated with both P-TIOX and Tixel, while the other side will receive Tixel only. The study will last about 9 weeks and will include several treatments and evaluations using photos and expert assessments. Participants may notice improvement in the skin around their eyes. The results will help doctors understand if this combination treatment is more effective.
Primary Outcome
Objective change in periocular fine lines and wrinkles will be measured using the Canfield Visia skin photography analysis system.
Conditions Studied
Interventions
- COMBINATION_PRODUCT Split-Face Tixel Treatment With and Without Topical Peptide-Based Cosmeceutical (P-TIOX)
Study Locations (1)
Pennsylvania
- Main Line Center for Laser Surgery - Ardmore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-06-01 |
| Est. Completion | 2027-06-01 |
| Phase | NA |
What the registry record for NCT07222176 still lists
NCT07222176 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Periocular Fine Wrinkles appearing as the primary indexed condition, and to 1 intervention - of which Split-Face Tixel Treatment With and Without Topical Peptide-Based Cosmeceutical (P-TIOX) is the first listed.
NCT07222176 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT07222176 about?
NCT07222176 is a clinical study titled "Effects of P-TIOX and Tixel Combined on Reducing Eye Wrinkles". This study looks at whether using a cosmeceutical called P-TIOX together with a treatment called Tixel can reduce fine lines and wrinkles around the eyes better than Tixel treatment alone. Tixel is an FDA-approved device that uses heat to improve skin texture and firmness. P-TIOX is a topical produc...
What is the current status of trial NCT07222176?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2025-06-01. Estimated completion is 2027-06-01.
What conditions does trial NCT07222176 study?
This clinical trial studies the following conditions: Periocular Fine Wrinkles.
What interventions are being tested in trial NCT07222176?
The interventions under investigation include: Split-Face Tixel Treatment With and Without Topical Peptide-Based Cosmeceutical (P-TIOX) (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT07222176?
This trial is sponsored by Main Line Center for Laser Surgery, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07222176 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07222176's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI